What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Antibiotics
- Bacteria
Mark H. Wilcox mostly deals with Clostridium difficile, Microbiology, Internal medicine, Intensive care medicine and Surgery.
His Clostridium difficile research is under the purview of Antibiotics.
His Microbiology research includes elements of Ribotyping and Bacteria.
His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology and Cefotaxime.
Mark H. Wilcox focuses mostly in the field of Intensive care medicine, narrowing it down to matters related to Bezlotoxumab and, in some cases, Pharmacotherapy and Fidaxomicin.
His Surgery research is multidisciplinary, incorporating elements of Adverse effect and Vancomycin.
His most cited work include:
- Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) (2506 citations)
- epic3: National Evidence-Based Guidelines for Preventing Healthcare-Associated Infections in NHS Hospitals in England (1093 citations)
- Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) (1087 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Clostridium difficile, Microbiology, Internal medicine, Antibiotics and Intensive care medicine.
His research in Clostridium difficile intersects with topics in Feces, Metronidazole, Virology, Vancomycin and Diarrhea.
His Microbiology study combines topics in areas such as Ribotyping and Gut flora.
His Internal medicine research incorporates themes from Gastroenterology and Surgery.
His Antibiotics study combines topics from a wide range of disciplines, such as Immunology and Staphylococcus aureus.
His study in Epidemiology extends to Intensive care medicine with its themes.
He most often published in these fields:
- Clostridium difficile (56.53%)
- Microbiology (51.17%)
- Internal medicine (21.87%)
What were the highlights of his more recent work (between 2018-2021)?
- Microbiology (51.17%)
- Clostridium difficile (56.53%)
- Internal medicine (21.87%)
In recent papers he was focusing on the following fields of study:
Mark H. Wilcox mainly investigates Microbiology, Clostridium difficile, Internal medicine, Antibiotics and Vancomycin.
The various areas that he examines in his Microbiology study include Clostridium and Bacteroides.
He combines subjects such as Virology, Whole genome sequencing, Single-nucleotide polymorphism, Genotype and Nucleic Acid Amplification Tests with his study of Clostridium difficile.
His Internal medicine study incorporates themes from Gastroenterology and Bezlotoxumab.
His studies deal with areas such as Spore germination, Microbiome, Dysbiosis and Intensive care medicine as well as Antibiotics.
His research integrates issues of Broth microdilution, In vitro, Incidence and Metronidazole in his study of Vancomycin.
Between 2018 and 2021, his most popular works were:
- A Role for Tetracycline Selection in Recent Evolution of Agriculture-Associated Clostridium difficile PCR Ribotype 078. (40 citations)
- Shedding of SARS-CoV-2 in feces and urine and its potential role in person-to-person transmission and the environment-based spread of COVID-19. (37 citations)
- Clostridium difficile: Investigating Transmission Patterns Between Infected and Colonized Patients Using Whole Genome Sequencing. (24 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Bacteria
- Antibiotics
Mark H. Wilcox mostly deals with Microbiology, Clostridium difficile, Internal medicine, Antibiotic resistance and Antibiotics.
He has included themes like Transmission, Virulence and Clostridium in his Microbiology study.
His Clostridium difficile research is multidisciplinary, incorporating elements of Clade, Clindamycin and Single-nucleotide polymorphism, Multilocus sequence typing, Genotype.
His Internal medicine research is multidisciplinary, incorporating perspectives in Bezlotoxumab, Vancomycin and Methicillin-resistant Staphylococcus aureus.
His research in the fields of Antimicrobial stewardship overlaps with other disciplines such as Index.
His Antibiotics research incorporates elements of Microbiome, Medical prescription and Cohort.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
